The relationship between the NHS and the pharmaceutical sector is ‘suboptimal’ because of the misalignment of ‘ambitions, constraints and risk appetites’, according to former National Institute for Health and Care Excellence Sir Andrew Dillon.
Multiple failings have been identified in how a leading cancer trust entered into a £20m research partnership with a large pharmaceutical company, and how bosses then reacted to concerns raised by staff.
The covid-19 vaccine will be delivered at almost half of planned capacity when the vaccination programme is rolled out tomorrow, according to new national guidance.
Selected community pharmacies will provide up to 1,000 coronavirus vaccines each week, in addition to those provided by general practice and mass centres, according to an NHS England letter.
The health service is setting up more than 40 mass vaccination centres, and working on recruiting tens of thousands of staff for the huge covid-19 vaccination effort, HSJ has learned.
An official review carried out for the health secretary, leaked to HSJ, reveals plans to bolster the law to require greater sharing of patient data, saying it would help improve safety for those wrongly prescribed drugs.
The NHS England chief executive has publicly accused a pharma company of ”using the cover of coronavirus to try and price-gouge British taxpayers” — a claim the firm has strongly denied.
Pharmacies are warning people are at risk of not getting the flu jab unless an urgent decision is made over the winter vaccination programme.
A government review says the financial interests of all doctors should be published on the General Medical Council’s register, due to concerns around potential conflicts of interest.
The NHS has “either lost sight of the interests of all those it was set up to serve or does not know how best to do this”, a major government-commissioned review has concluded.
The government and healthcare system “will not be forgiven” if they fail to act on a major report which reveals “institutional” resistance in the NHS to patient safety concerns, its authors warned today.
The need to respond at scale and pace to the coronavirus pandemic has created unprecedented collaboration between the NHS and the pharmaceutical and medical devices sector.
The Department for Health and Social Care paid at least £3.15m on a bulk order of hydroxychloroquine tablets in April for clinical trials, after reportedly spending £2m on the drug in March.
The first results of clinical trials into therapeutic drugs used to treat covid-19 patients could be available before the end of June, according to an NHS letter.
The government has banned the parallel export of more than 80 drugs to protect the national supply of key medicines.
The National Institute for Health and Care Excellence’s deputy chief executive will replace founding CEO Sir Andrew Dillon, after he steps down this month.
The government has appointed a health minister in the Lords, who will lead on innovation and life sciences.
LloydsPharmacy Clinical Homecare and the Perinatal Institute were among the winners at the HSJ Partnership Awards 2020.
Legionella and pseudomonas were found in water meant for hand washing in a unit where medicines for cancer patients were prepared, HSJ has learned.
The Department of Health and Social Care has told trusts not to stockpile products, amid growing concern over the impact of novel coronavirus on medical supplies.
A specialist trust is being sued for nearly £2m by a Luxembourgian pharmaceutical company over allegations of wrongdoing by the provider’s subsidiary company, HSJ can reveal.
Former health secretary Jeremy Hunt has urged his successor to find a way to ensure patients can access a high cost drug which is subject to a legal challenge against the National Institute for Health and Care Excellence.
A national strategy is needed to tackle health risks linked to antipsychotic drugs because current policy is letting tens of thousands of people fall through the gaps, commissioners in London are warning.
Poorly-implemented electronic prescribing systems in NHS hospitals are putting patients’ lives at risk, the NHS’s safety watchdog has warned.
A deal has been struck to make a life-extending cystic fibrosis drug available on the NHS for the first time.
The NHS will be exposed to more risk by the government’s latest Brexit deal than by Theresa May’s original agreement, health service experts and lobby groups have told HSJ.
Ministers have confirmed plans for a ban on the export of certain medicines, starting with a group of 24 drugs including 19 hormone replacement therapy treatments, ahead of the no-deal Brexit deadline at the end of this month.
Jeremy Corbyn says a Labour government would create a state-run pharmaceutical company to make generic versions of drugs the NHS cannot afford.
NHS chiefs have urged ministers to publish their up-to-date plans for a no-deal Brexit, in the wake of the release of Project Yellowhammer documents.
Fresh concerns have been raised that drugs stockpiled for a no-deal Brexit could be sold off before the 31 October deadline unless ministers intervene.